<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02955407</url>
  </required_header>
  <id_info>
    <org_study_id>2016-00647</org_study_id>
    <nct_id>NCT02955407</nct_id>
  </id_info>
  <brief_title>Genetic Predisposition for Chronic Non-specific Low Back Pain</brief_title>
  <acronym>Backgene</acronym>
  <official_title>Genetic Predisposition for Reduced Back Muscle Strength and Back Muscle Endurance in Patients With Chronic Non-specific Low Back Pain</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Balgrist University Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Balgrist University Hospital</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Patients with inflammatory back pain were shown to differ from healthy controls in genotype
      of the Angiotensin-converting enzyme (ACE), which regulates vasoconstriction/-dilatation. The
      aim of this study is to investigate whether genetic reduction of muscle perfusion might be a
      pathophysiological pathway of how genes influence chronic non-specific low back pain (LBP).
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      The following genes will be investigated:

        -  Insertions-/deletions-polymorphism of the angiotensin-converting enzyme (ACE-I/D gene
           polymorphism; 3 genotypes: ACE-II, ACE-ID, ACE-DD).

        -  Anti-adhesive extracellular matrix protein Tenascin-C: gene polymorphism rs2104772

      The goals of this study are to investigate whether these genotypes correlate with 1)
      endurance of back muscles, 2) comorbidities such as asthma and diabetes and 3) the risk for
      LBP as assessed by a LBP-classification tool.
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date>September 2016</start_date>
  <completion_date type="Anticipated">March 2018</completion_date>
  <primary_completion_date type="Anticipated">March 2018</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Cross-Sectional</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Polymorphism ACE Gene</measure>
    <time_frame>baseline</time_frame>
  </primary_outcome>
  <primary_outcome>
    <measure>Polymorphism Tenascin Gene</measure>
    <time_frame>baseline</time_frame>
  </primary_outcome>
  <secondary_outcome>
    <measure>Back muscle endurance in Sorensen test</measure>
    <time_frame>baseline</time_frame>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Anticipated">100</enrollment>
  <condition>Low Back Pain</condition>
  <arm_group>
    <arm_group_label>Low back pain patients</arm_group_label>
    <description>Low back pain since more than 3 months Age: 18-65 Caucasian race</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Controls without low back pain</arm_group_label>
    <description>no low back ain Age: 18-65 Caucasian race</description>
  </arm_group>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>no intervention</intervention_name>
    <description>observational case-control study</description>
    <arm_group_label>Low back pain patients</arm_group_label>
    <arm_group_label>Controls without low back pain</arm_group_label>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Patients with chronic low back pain and healthy controls without low back pain.
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-65

        Exclusion Criteria:

          -  Spinal surgery

          -  Spinal fracture

          -  Inflammation

          -  Tumour

          -  Severe chronic disease which make intensive physical activity impossible
             (osteoporosis, cardiovascular heart diseases)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Martin Fl端ck, Professor</last_name>
    <role>Study Director</role>
    <affiliation>Balgrist University Hospital</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Barry K Humphreys, Professor</last_name>
    <phone>+41 386 57 02</phone>
    <email>kim.humphreys@balgrist.ch</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Brigitte Wirth, PhD</last_name>
    <phone>+41 386 57 03</phone>
    <email>brigitte.wirth@balgrist.ch</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Balgrist University Hospital</name>
      <address>
        <city>Zurich</city>
        <zip>8008</zip>
        <country>Switzerland</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Martin Fl端ck, Prof</last_name>
      <phone>+41 44 510 73 50</phone>
      <email>martin.fl端ck@balgrist.ch</email>
    </contact>
    <contact_backup>
      <last_name>Barry Kim Humphreys, Prof</last_name>
      <phone>+41 44 386 57 02</phone>
      <email>kim.humphreys@balgrist.ch</email>
    </contact_backup>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <reference>
    <citation>Vaughan D, Huber-Abel FA, Graber F, Hoppeler H, Fl端ck M. The angiotensin converting enzyme insertion/deletion polymorphism alters the response of muscle energy supply lines to exercise. Eur J Appl Physiol. 2013 Jul;113(7):1719-29. doi: 10.1007/s00421-012-2583-6. Epub 2013 Feb 9.</citation>
    <PMID>23397151</PMID>
  </reference>
  <reference>
    <citation>Shehab DK, Al-Jarallah KF, Al-Awadhi AM, Al-Herz A, Nahar I, Haider MZ. Association of angiotensin-converting enzyme (ACE) gene insertion-deletion polymorphism with spondylarthropathies. J Biomed Sci. 2008 Jan;15(1):61-7. Epub 2007 Aug 23.</citation>
    <PMID>17713861</PMID>
  </reference>
  <verification_date>February 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 6, 2016</study_first_submitted>
  <study_first_submitted_qc>November 3, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">November 4, 2016</study_first_posted>
  <last_update_submitted>February 25, 2018</last_update_submitted>
  <last_update_submitted_qc>February 25, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">February 27, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
    <mesh_term>Disease Susceptibility</mesh_term>
    <mesh_term>Genetic Predisposition to Disease</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

